Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06078527
Other study ID # 232011
Secondary ID NCI-2023-10667
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date August 1, 2024
Est. completion date March 31, 2026

Study information

Verified date June 2024
Source University of California, San Francisco
Contact James Lappin, Jr.
Phone 877-827-3222
Email james.lappin@ucsf.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A previous study completed in 2022 (NCT05158179) was conducted using cohorts of healthy controls, and adults with general laryngopharyngeal disorders. This study will expand on the previous research to include a separate cohort of adults being seen in clinic for an existing laryngopharyngeal disorder resulting from previous radiation or other cancer treatments.


Description:

PRIMARY OBJECTIVES: I. Laryngeal sensation as measured by elicitation of laryngeal adductor reflex (LAR). II. To compare the elicitation of laryngeal adductor reflex (LAR) threshold/probability to the Penetration-Aspiration Scale (PAS). SECONDARY OBJECTIVES: I. To assess patient-reported laryngeal sensation (PRLS) following stimulus and perceptual strength. II. To assess laryngopharyngeal responses (e.g., cough, gag, swallow) following stimulus. III. To assess patient reported outcomes (PROs). EXPLORATORY OBJECTIVES: I. To compare the elicitation of laryngeal adductor reflex (LAR) threshold/probability to: - modified barium swallow (MBS) study kinematics; - MBS Dynamic Imaging Grade of Swallowing Toxicity (MBS DIGEST); - MD Anderson Dysphagia Inventory patient reported outcomes measure (MDADI PROMs); - Dynamic Imaging Grade of Swallowing Toxicity for Flexible Endoscopic Evaluation of Swallowing (DIGEST-FEES) - Flexible Endoscopic Evaluation of Swallowing Visual Analysis of Swallowing Efficiency and Safety (FEES VASES). OUTLINE: Participants receiving care at University of California, San Francisco (UCSF) for an existing laryngopharyngeal disorder resulting from previous radiation or other cancer treatments will undergo laryngopharyngeal sensory testing at a single visit. There will be up to 2 years of medical record follow up after completing the main study. Data collected from this separate cohort may be compared with historical data collected in a previous study (NCT05158179).


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 40
Est. completion date March 31, 2026
Est. primary completion date March 31, 2026
Accepts healthy volunteers No
Gender All
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria: 1. Age <=18 years. 2. Individuals without a laryngopharyngeal disorder (health controls) or with a laryngopharyngeal disorder. Laryngopharyngeal disorder includes but is not limited to: presbylarynx, aspiration; spasmodic dysphonia; globus pharynges; vocal fold paralysis; iatrogenic injury to the larynx; muscle tension dysphonia; neurogenic dysphagia; laryngeal sensory neuropathy; and laryngopharyngeal disorders resulting from prior radiation therapy in individuals with a history of head and neck cancer who have completed radiation therapy as primary or adjuvant cancer treatment 3. Ability and willingness to comply with study procedures. 4. Ability to understand a written informed consent document, and the willingness to sign it. Exclusion Criteria: 1. Non-English speaking. 2. Laryngopharyngeal structures are not accessible on exam. 3. Known contraindication to any study-related procedure, or history of being unable to tolerate laryngoscopy. 4. Vocal fold immobility or severe hypomobility on adduction. 5. For head and neck cancer survivors only: Currently undergoing radiation therapy for head and neck cancer (i.e., primary/adjuvant radiation therapy treatment plan is not yet completed).

Study Design


Intervention

Device:
Cheung-Bearelly Aesthesiometer
The Cheung-Bearelly Aesthesiometer will be used to deliver a range of calibrated stimuli through the channeled flexible laryngoscope to assess sensation of the laryngopharynx.
Procedure:
Transnasal Laryngoscopy
A procedure to examine your larynx (voice box)
Other:
Questionnaires
Patient-reported health and behavioral outcomes measures will be administered

Locations

Country Name City State
United States University of California, San Francisco San Francisco California

Sponsors (2)

Lead Sponsor Collaborator
University of California, San Francisco National Spasmodic Dysphonia Association

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Percentage of participants with triggered/positive laryngeal adduction response (LAR) Elicitation of LAR is defined as a unilateral or bilateral laryngeal adduction immediately following laryngeal stimulus through frame-by-frame analysis of video recordings (visualized on laryngoscopy). An acceptable tactile stimulus is near orthogonal (less than 30 degrees deviation) to the mucosal surface and unobstructed by salivary forces. The percentage of participants with LAR will be reported 1 day
Primary Median scores on the Penetration-Aspiration Scale (PAS) The PAS is a widely-used ordinal scale metric used to describe severity of aspiration. The PAS score is multidimensional, i.e., include several observations within each score: (1) depth of airway invasion (material above, contacting, or below the level of vocal folds; (2) whether or not there is material remaining after the swallow (ejected, not ejected); and (3) the patient's response to material present in the airway (effort to clear the material). The PAS is an 8-point ordinal scale, with a total score ranging from 1 representing the least and 8 representing the highest or most severe score. 1 day
Secondary Median scores on the participant-reported laryngeal sensation (PRLS) The PRLS is defined as a binary response to participants' self-reported detection of laryngeal stimulation. Once the participant indicates they perceived the stimulus, the research team will ask the participant to provide a perceptual strength rating on a 1-10 scale, with higher scores indicated a greater strength of stimulus. 1 day
Secondary Percentage of participants with visualized laryngopharyngeal responses Percentage of participants with visualized laryngopharyngeal responses (e.g., cough, gag, swallow) following stimulus will be recorded by the clinician and reported. 1 day
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04083677 - Routine Point of Care Ultrasound (POCUS) Assessment of Antral Gastric Contents in Traumatic Surgical Patients for Prevention of Aspiration Pneumonitis
Terminated NCT05101668 - Safety and Efficacy of Intracranial Thrombus Aspiration Catheter in the Treatment of Acute Large-vessel Occlusive Stroke N/A
Completed NCT02588495 - Accuracy of Gastric Ultrasound to Diagnose a "Full Stomach". A Bayesian Framework N/A
Completed NCT02576756 - Retrospective Study in Patients Who Have Had a Difficult Intubation. N/A
Completed NCT01777672 - Effect of Afferent Oropharyngeal Pharmacological and Electrical Stimulation on Swallow Response and on Activation of Human Cortex in Stroke Patients With Oropharyngeal Dysphagia Phase 2
Completed NCT05033041 - Gastric Volumes by US in Term Parturients Undergoing CS With and Without Metoclopramide Phase 4
Recruiting NCT05079620 - Early Antibiotics After Aspiration in ICU Patients Phase 4
Completed NCT01011803 - Correlation of Phonation With Deglutition and Aspiration Risk in the ICU Patients - an Exploratory Study N/A
Recruiting NCT06137976 - Surgeon Perception of Gastric Decompression at Time of Gynecologic Laparoscopy N/A
Completed NCT04645043 - Ultrasound Guided Esophageal Pressure N/A
Completed NCT01807884 - Comparison of Two Strategies of Oropharyngeal and Tracheal Suctioning in Mechanically Ventilated Patients N/A
Completed NCT03555604 - Evaluation of the Effect of Body Mass Index on Gastric Volume With Ultrasound in Term Pregnant Women
Completed NCT03573609 - Evaluation of the Effectiveness and Safety of Supratube Device N/A
Enrolling by invitation NCT04411290 - Malignancy Predictors, Bethesda and TI-RADS Scores Correlated With Final Histopathology in Thyroid Diseases
Completed NCT05734937 - Ultrasound Evaluation of Gastric Volume in Pediatric Patients Undergoing Adenotonsillectomy Surgery N/A
Recruiting NCT05330351 - Gastric Ultrasound in Pediatric Trauma Patients
Terminated NCT02437513 - NewBreez for Airway Protection in Head and Neck Cancer Patients With Chronic Aspiration N/A
Completed NCT04786691 - How do You Take Your Coffee Before Anesthesia N/A
Completed NCT05434442 - Caregivers Tracheal Aspiration Training N/A
Completed NCT03305757 - Seroma Reduction After Mastectomy Phase 4